Dinesh M. Kumar - 01 Aug 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Officer
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
01 Aug 2024
Transactions value $
-$40,947
Form type
4
Date filed
05 Aug 2024, 20:10
Previous filing
24 Jan 2024
Next filing
12 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Tax liability -$40.9K -794 -0.53% $51.57 150K 01 Aug 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.
F2 Includes 147,132 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025; (ii) 16,316 shares, which will vest subject to the achievement of certain pre-established performance goals; (iii) 16,316 shares, which will vest subject to the achievement of certain pre-established performance goals; (iv) 13,053 shares, which will vest subject to the achievement of certain pre-established performance goals; (v) 9,790 shares, which will vest in three equal semi-annual installments beginning on January 1, 2025; and (vi) 6,527 shares, which will vest subject to the achievement of certain pre-established performance goals.

Remarks:

Chief Medical Officer of Astrana Health Enablement of Nevada, Inc., a wholly owned subsidiary of Astrana Health, Inc. Effective February 26, 2024, the Issuer changed its legal name from Apollo Medical Holdings, Inc. to Astrana Health, Inc. Power of Attorney is attached hereto as Exhibit 24.